RECRUITING

Low Systemic/High Local Exercise Load in Peds SCD

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research study wants to learn about what kind of exercise is best for kids with sickle cell disease. Participating children will have a small amount of blood drawn one time at the beginning of the study. Children will then complete some questionnaires that measure pain, physical function, and emotions (depression, anxiety) and complete some tests that measure physical fitness at the beginning and end of the study. Children will be randomized to either a home-based telehealth (1) walking or (2) strengthening exercise program that lasts for 8-weeks, 3-x week, for 45 minutes each session. Children's participation will last up to 10 weeks.

Official Title

Low Systemic/High Local Exercise Load in Pediatric Sickle Cell Disease

Quick Facts

Study Start:2023-09-19
Study Completion:2025-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06387758

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:12 Years to 17 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * youth 12 to 17 years old
  2. * diagnosed with SCD genotype SS, SC, beta-plus thalassemia, or beta-zero thalassemia
  3. * has daily access to an Internet enabled device (e.g., smart phone, IPad) A parent (≥21 years old) will also be recruited for each youth participant.
  1. * non-English speaking due to lack of available written translation services for informed consent and questionnaires
  2. * cognitive impairment (e.g., moderate to profound intellectual disability) that precludes study completion
  3. * medical condition (e.g., hypertension, bone fracture) that precludes completing exercise safely (determined by study medical director Dr. McNaull).

Contacts and Locations

Study Contact

Cynthia W Karlson, PhD
CONTACT
6019842723
ckarlson@umc.edu
Rhonda Aikens
CONTACT
601-984-2716
raikens@umc.edu

Principal Investigator

Yolanda Griffin
STUDY_DIRECTOR
Director-Clinical Trials Office

Study Locations (Sites)

University of Mississippi Medical Center
Jackson, Mississippi, 39216
United States

Collaborators and Investigators

Sponsor: University of Mississippi Medical Center

  • Yolanda Griffin, STUDY_DIRECTOR, Director-Clinical Trials Office

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-19
Study Completion Date2025-06-30

Study Record Updates

Study Start Date2023-09-19
Study Completion Date2025-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Sickle Cell Anemia in Children